Prediction of pathological complete response after neoadjuvant chemotherapy for HER2-negative breast cancer patients with routine immunohistochemical markers

Abstract Background Pathological complete response (pCR) is an established surrogate marker for prognosis in patients with breast cancer (BC) after neoadjuvant chemotherapy. Individualized pCR prediction based on clinical information available at biopsy, particularly immunohistochemical (IHC) marker...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Lothar Häberle, Ramona Erber, Paul Gass, Alexander Hein, Melitta Niklos, Bernhard Volz, Carolin C. Hack, Rüdiger Schulz-Wendtland, Hanna Huebner, Chloë Goossens, Matthias Christgen, Thilo Dörk, Tjoung-Won Park-Simon, Andreas Schneeweiss, Michael Untch, Valentina Nekljudova, Sibylle Loibl, Arndt Hartmann, Matthias W. Beckmann, Peter A. Fasching
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	BMC 2025-01-01
Cyfres:	Breast Cancer Research
Pynciau:	pCR Prediction model Breast cancer Neoadjuvant chemotherapy Immunohistochemistry Clinical data
Mynediad Ar-lein:	https://doi.org/10.1186/s13058-025-01960-8
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!